ANOVA for DH (Y₁) and IC₅₀ of LI (Y₂). by Kittisak Kuptawach (18599047)

“…The peptide was synthesized and demonstrated LI with an IC₅₀ of 0.255 mM through a non-competitive mechanism, with a constant (K_i) of 0.61 mM. …”

Decreased pMHC avidity and CD8β-independence for functional avidity of D^bNPN3A-primed T cells for D^bNP₃₆₆. by Sophie A. Valkenburg (176257)

Prognosis and risk factors of chronic kidney disease progression in patients with diabetic kidney disease and non-diabetic kidney disease: a prospective cohort CKD-ROUTE study by Shengnan Chen (3595319)

“…The secondary endpoints were all-cause death and the development of cardiovascular disease (CVD) events. We found that DKD patients have a higher risk to develop 50% eGFR decline endpoint (HR:2.30, 95%CI [1.48–3.58], <i>p</i> < 0.001) and KRT endpoint (HR:1.64, 95%CI [1.13–2.37], <i>p</i> < 0.05) than NDKD patients. …”

EB (Ethyl Butyrate) as a Cosolvent of Electrolyte Tuning an Ultrathin CEI Membrane for Improving the Ultralow-Temperature Behaviors of LiNi_0.8Co_0.1Mn<sub>0.1<... by Lucheng Li (13753395)

“…Besides, the electrochemical properties of the batteries during cold conditions can be obviously improved by adding EB. In addition, after 50 cycles of −40 °C, the basic electrolyte has a discharge capacity of 81.94 mAh g^–1; on the contrary, the cells using the 16 EB-modified coreagent maintains a discharge capacity of 112.3 mAh g^–1 under the same conditions. …”

EB (Ethyl Butyrate) as a Cosolvent of Electrolyte Tuning an Ultrathin CEI Membrane for Improving the Ultralow-Temperature Behaviors of LiNi_0.8Co_0.1Mn<sub>0.1<... by Lucheng Li (13753395)

“…Besides, the electrochemical properties of the batteries during cold conditions can be obviously improved by adding EB. In addition, after 50 cycles of −40 °C, the basic electrolyte has a discharge capacity of 81.94 mAh g^–1; on the contrary, the cells using the 16 EB-modified coreagent maintains a discharge capacity of 112.3 mAh g^–1 under the same conditions. …”

Fluorescence-based identification of myoblast cells. by Lihong Gu (513505)

Changes in the number of muscle fibers per unit area in pectoral muscle tissue of <i>Wenchang chicken</i> embryos from embryonic day 7 to embryonic day 15. by Lihong Gu (513505)

Association between CVR components^b'*' and depressive status (BDI-II ≥18) in the PREDIMED-PLUS trial. by Sandra Martín-Peláez (11353470)

The CaM-binding mutation in PC1 decreases macroscopic current through PC1/PC2 channels. by Nicholas Doerr (2446855)

Fig 3 - by Lihong Gu (513505)

Changes in the positions of cells and the trajectories of cells of different sizes at the microscopic level. by Lihong Gu (513505)

Cell characterization following pectoral muscle dissociation. by Lihong Gu (513505)

Cell morphology and corresponding cell diameters at each outlet. by Lihong Gu (513505)

Image_1_Samm50 Promotes Hypertrophy by Regulating Pink1-Dependent Mitophagy Signaling in Neonatal Cardiomyocytes.TIF by Ran Xu (316855)

“…We first found that Samm50 is a key positive regulator of cardiac hypertrophy, for western blot and real-time quantitative PCR detection revealed Samm50 was downregulated both in pressure-overload-induced hypertrophic hearts and Ang II-induced cardiomyocyte hypertrophy. …”

Table_1_Samm50 Promotes Hypertrophy by Regulating Pink1-Dependent Mitophagy Signaling in Neonatal Cardiomyocytes.XLSX by Ran Xu (316855)

“…We first found that Samm50 is a key positive regulator of cardiac hypertrophy, for western blot and real-time quantitative PCR detection revealed Samm50 was downregulated both in pressure-overload-induced hypertrophic hearts and Ang II-induced cardiomyocyte hypertrophy. …”

Table_2_Samm50 Promotes Hypertrophy by Regulating Pink1-Dependent Mitophagy Signaling in Neonatal Cardiomyocytes.XLSX by Ran Xu (316855)

“…We first found that Samm50 is a key positive regulator of cardiac hypertrophy, for western blot and real-time quantitative PCR detection revealed Samm50 was downregulated both in pressure-overload-induced hypertrophic hearts and Ang II-induced cardiomyocyte hypertrophy. …”

Performance as a function of increasing amplitude of fixational eye movements. by Phillip Bedggood (485619)

Baseline characteristics of the study participants. by Sandra Martín-Peláez (11353470)

Flow chart for the analysis of cardiovascular risk and depression in the PREDIMED-PLUS trial. by Sandra Martín-Peláez (11353470)

Baseline characteristics of participants. by Liya Xu (761537)

“…<div><p>Objectives</p><p>To explore the relationship between hand grip strength (HGS) and blood pressure in physically disabled individuals over 50 years old.</p><p>Methods</p><p>The research adopts a cross-sectional survey, and the data comes from the “2022–2023 Physical Health Monitoring and Scientific and Technological Services for Physical Disabilities” jointly carried out by Beijing Sport University and China Disabled Sports Management Center. …”